Why the study?
To evaluate whether achieving the SDG 3.4 target of reducing premature non-communicable disease mortality by one-third by 2030 is feasible in China by investigating subnational progress in reducing premature CVD mortality.
China is on track to achieve the SDG 3.4 goal of a one-third reduction in premature cardiovascular mortality by 2030, though the burden remains significantly higher in males.
No takes yet. Share an insight, caveat, or question.
Projections indicate SDG 3.4 CVD target feasibility in China; leaves open whether male-specific strategies will close gaps in real-world settings.
Zhao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: